Effect of Adding Inhaled Corticosteroid to Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist Therapy Among Patients With Chronic Obstructive Pulmonary Disease

Background The role of inhaled corticosteroid (ICS) in chronic obstructive pulmonary disease (COPD) is unclear. Hence, this study aimed to evaluate the efficacy of ICS as an add-on to long-acting muscarinic antagonist (LAMA)/long-acting beta 2 agonist (LABA), which was assessed using the impulse osc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuasa, Mizuki, Tanaka, Yosuke, Tanaka, Tohru, Kashiwada, Takeru, Taniuchi, Namiko, Saito, Yoshinobu, Seike, Masahiro, Hino, Mitsunori, Gemma, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632595/
https://www.ncbi.nlm.nih.gov/pubmed/34873511
http://dx.doi.org/10.7759/cureus.19168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632595/
https://www.ncbi.nlm.nih.gov/pubmed/34873511
http://dx.doi.org/10.7759/cureus.19168

Ejemplares similares